DXCM
Dexcom Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$64.24
-1.02 ▼ -1.56%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$64.58
+0.34 ▲ +0.53%
| Index | NDX, S&P 500 | P/E | 30.69 | EPS (ttm) | 2.09 | Insider Own | 1.4% | Shs Outstand | 0.38B | Perf Week | -5.67% |
| Market Cap | 24.72B | Forward P/E | 21.5 | EPS next Y | 20.03% | Insider Trans | 0.17% | Shs Float | 0.38B | Perf Month | -5.74% |
| Enterprise Value | 24.11B | PEG | 1.1 | EPS next Q | 0.47 | Inst Own | 95.99% | Short Float | 4.04% | Perf Quarter | -4.91% |
| Income | 0.84B | P/S | 5.3 | EPS this Y | 19.1% | Inst Trans | -2.22% | Short Ratio | 3.04 | Perf Half Y | -15.47% |
| Sales | 4.66B | P/B | 9 | EPS next 5Y | 19.53% | ROA | 13.04% | Short Interest | 15.32M | Perf YTD | -3.21% |
| Book/sh | 7.14 | P/C | 12.37 | EPS past 3/5Y | 37.83% 10.55% | ROE | 34.5% | 52W High | -28.61% ($89.98) | Perf Year | -6.19% |
| Cash/sh | 5.19 | P/FCF | 22.95 | Sales past 3/5Y | 17.01% 19.33% | ROIC | 20.33% | 52W Low | 18.72% ($54.11) | Perf 3Y | -41.95% |
| Dividend Est. | - | EV/EBITDA | 20.72 | EPS Y/Y TTM | 46.46% | Gross Margin | 60.44% | Volatility(W/M) | 3.27% 3.6% | Perf 5Y | -28.17% |
| Dividend TTM | - | EV/Sales | 5.17 | Sales Y/Y TTM | 15.6% | Oper. Margin | 19.56% | ATR (14) | 2.28 | Perf 10Y | 294.41% |
| Dividend Ex-Date | - | Quick Ratio | 1.59 | EPS Q/Q | 77.97% | Profit Margin | 17.94% | RSI (14) | 29.93 | Recom | 1.55 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.88 | Sales Q/Q | 13.12% | SMA20 | -9.32% ($70.84) | Beta | 1.55 | Target Price | $86.44 |
| Payout | - | Debt/Eq | 0.51 | Earnings | 2000000 | SMA50 | -8.91% ($70.52) | Rel Volume | 0.81 | Prev Close | $65.26 |
| Employees | 11100 | LT Debt/Eq | 0.5 | EPS/Sales Surpr. | 4.65% 0.91% | SMA200 | -12.03% ($73.02) | Avg Volume(3M) | 5.05M | Price | $64.24 |
| IPO | 2005/4/14 | Option/Short | Yes/Yes | Trades | 40418 | Volume | 4,075,952 | Change | -1.56% |
뉴스 로딩 중...